IL96167A - Amides of G-] 1,3-Dihydro-H) -22 (- Oxo-7-imidazo] B-5, 4 [- Quinolinylloxy [Alcanoic, their preparation and pharmaceutical preparations that contain them - Google Patents

Amides of G-] 1,3-Dihydro-H) -22 (- Oxo-7-imidazo] B-5, 4 [- Quinolinylloxy [Alcanoic, their preparation and pharmaceutical preparations that contain them

Info

Publication number
IL96167A
IL96167A IL9616790A IL9616790A IL96167A IL 96167 A IL96167 A IL 96167A IL 9616790 A IL9616790 A IL 9616790A IL 9616790 A IL9616790 A IL 9616790A IL 96167 A IL96167 A IL 96167A
Authority
IL
Israel
Prior art keywords
oxo
dihydro
imidazo
quinolin
piperazine
Prior art date
Application number
IL9616790A
Other languages
English (en)
Hebrew (he)
Other versions
IL96167A0 (en
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL96167A0 publication Critical patent/IL96167A0/xx
Publication of IL96167A publication Critical patent/IL96167A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9616790A 1989-11-01 1990-10-30 Amides of G-] 1,3-Dihydro-H) -22 (- Oxo-7-imidazo] B-5, 4 [- Quinolinylloxy [Alcanoic, their preparation and pharmaceutical preparations that contain them IL96167A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/430,228 US4943573A (en) 1989-11-01 1989-11-01 Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility

Publications (2)

Publication Number Publication Date
IL96167A0 IL96167A0 (en) 1991-07-18
IL96167A true IL96167A (en) 1994-11-11

Family

ID=23706624

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9616790A IL96167A (en) 1989-11-01 1990-10-30 Amides of G-] 1,3-Dihydro-H) -22 (- Oxo-7-imidazo] B-5, 4 [- Quinolinylloxy [Alcanoic, their preparation and pharmaceutical preparations that contain them

Country Status (20)

Country Link
US (1) US4943573A (sh)
EP (1) EP0426180A3 (sh)
JP (1) JPH03169880A (sh)
KR (1) KR910009705A (sh)
CN (1) CN1025999C (sh)
AU (1) AU639033B2 (sh)
CA (1) CA2027935A1 (sh)
EG (1) EG19372A (sh)
FI (1) FI92697C (sh)
HU (1) HU209305B (sh)
IE (1) IE61579B1 (sh)
IL (1) IL96167A (sh)
MY (1) MY105308A (sh)
NO (1) NO175531C (sh)
NZ (1) NZ235868A (sh)
OA (1) OA09323A (sh)
PT (1) PT95765A (sh)
RU (1) RU2041210C1 (sh)
YU (1) YU205590A (sh)
ZA (1) ZA908725B (sh)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
US5348960A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5208237A (en) * 1992-04-03 1993-05-04 Bristol-Meyers Squibb Company 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5158958A (en) * 1992-04-03 1992-10-27 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
TW593317B (en) * 1993-06-21 2004-06-21 Janssen Pharmaceutica Nv Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
US5672622A (en) * 1994-04-21 1997-09-30 Berlex Laboratories, Inc. Treatment of multiple sclerosis
US6060501A (en) * 1994-06-02 2000-05-09 Schering Aktiengesellschaft Combined treatment of multiple sclerosis
WO1996005202A1 (fr) * 1994-08-17 1996-02-22 Nippon Hypox Laboratories Inc. Derive de l'imidazoquinoleine
US5798767A (en) * 1996-03-15 1998-08-25 Rendition, Inc. Method and apparatus for performing color space conversion using blend logic
SE9902987D0 (sv) * 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
US20030186963A1 (en) * 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US7064135B2 (en) 2001-10-12 2006-06-20 Novo Nordisk Inc. Substituted piperidines
EP2243776A1 (en) 2001-10-12 2010-10-27 High Point Pharmaceuticals, LLC Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
US8227603B2 (en) * 2006-08-01 2012-07-24 Cytokinetics, Inc. Modulating skeletal muscle
US8299248B2 (en) * 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
EP2995619B1 (en) * 2006-08-02 2019-09-25 Cytokinetics, Inc. Certain chemical entities comprising imidazopyrimidines, compositions and methods
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US7851484B2 (en) * 2007-03-30 2010-12-14 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0808968D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substitute quinazolines
GB0808967D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substitute quinazolines
GB0808952D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808947D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
BR112014000742A2 (pt) 2011-07-13 2016-08-23 Andrew A Wolff terapia de combinação de als
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
WO2024149378A1 (zh) * 2023-01-13 2024-07-18 上海超阳药业有限公司 喹啉酮化合物和萘啶酮化合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) * 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
NL7807507A (nl) * 1977-07-25 1979-01-29 Hoffmann La Roche Tricyclische verbindingen.
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
HU193409B (en) * 1984-02-15 1987-10-28 Syntex Inc Process for producing 2-square bracket -n-cyclohexyl-4-bracket-oxo-1,2,3,5-tetrahydro-imidazo-square bracket-2,1-b-square bracket closed-quinazolin-7-yl-bracket closed-oxy-alkqne-carboxamidyl-square bracket closed-alkan-acides
US4668686A (en) * 1985-04-25 1987-05-26 Bristol-Myers Company Imidazoquinoline antithrombrogenic cardiotonic agents
US4775674A (en) * 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
US4701459A (en) * 1986-07-08 1987-10-20 Bristol-Myers Company 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4943573A (en) * 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility

Also Published As

Publication number Publication date
AU6567990A (en) 1991-05-23
HU209305B (en) 1994-04-28
HUT56102A (en) 1991-07-29
EG19372A (en) 1994-12-30
IE903923A1 (en) 1991-05-08
CN1051359A (zh) 1991-05-15
NO904689D0 (no) 1990-10-30
FI905326A0 (fi) 1990-10-29
HU906977D0 (en) 1991-05-28
PT95765A (pt) 1991-09-13
CA2027935A1 (en) 1991-05-02
MY105308A (en) 1994-09-30
YU205590A (sh) 1992-09-07
IL96167A0 (en) 1991-07-18
EP0426180A2 (en) 1991-05-08
US4943573A (en) 1990-07-24
KR910009705A (ko) 1991-06-28
AU639033B2 (en) 1993-07-15
CN1025999C (zh) 1994-09-28
NO904689L (no) 1991-05-02
FI92697C (fi) 1994-12-27
NO175531B (no) 1994-07-18
NO175531C (no) 1994-10-26
ZA908725B (en) 1991-07-31
NZ235868A (en) 1993-12-23
JPH03169880A (ja) 1991-07-23
EP0426180A3 (en) 1992-01-08
IE61579B1 (en) 1994-11-16
OA09323A (en) 1992-09-15
RU2041210C1 (ru) 1995-08-09
FI92697B (fi) 1994-09-15

Similar Documents

Publication Publication Date Title
US4943573A (en) Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
KR900008567B1 (ko) 이미다조키놀리닐에테르 유도체의 제조방법
US4701459A (en) 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation
US4988698A (en) 2(1H)-quinolinone compounds and pharmaceutical composition comprising the same
JP5205276B2 (ja) 酵素阻害剤
NO168585B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridiner
AU6143899A (en) Fused pyridine inhibitors of cgmp phosphodiesterase
JP6301374B2 (ja) キナーゼ阻害剤としてのキナゾリン類
JP6246813B2 (ja) アミノキナゾリンキナーゼ阻害剤のプロドラッグ
PL195551B1 (pl) Dipodstawione dipierścieniowe związki heterocykliczne, ich sole, kompozycja farmaceutyczna je zawierająca, ich zastosowanie i sposób wytwarzania
CZ72393A3 (en) Sulfonylbenzyl-substituted benzopyridones and pyridopyridones
US5196428A (en) Imidazo[4,5-b]qinolinyl oxy alkyl ureas
US5912246A (en) Imidazo 1,2-a!pyridines for the treatment of CNS and cardiac diseases
JP2004521903A (ja) ＴＧＦ−β阻害剤としてのチアゾール化合物
US5208237A (en) 7-oxypropylsulfonamido-imidazo[4,5-b]quinolin-2-ones
AU2020430369A1 (en) Thieno[2,3-d]pyrimidine HIV-1 non-nucleoside reverse transcriptase inhibitor, preparation method therefor and use thereof
US6013654A (en) Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
US5348960A (en) Imidazo[4,5-b]quinolinyl oxy alkyl tetrazolyl piperidine derivatives
US5158958A (en) Imidazo[4,5-b]quinolinyl oxy alkyl sulfonyl piperidine derivatives
JPH09249661A (ja) オキシインドール誘導体
CZ20022016A3 (cs) Sacharinové deriváty jako orální aktivní inibitory elastasy
JPH05112559A (ja) ４−アミノ−５−ピリミジンカルボン酸誘導体

Legal Events

Date Code Title Description
RH Patent void